Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 11/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.49 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.49 |
| ▸ | FLT3 | P36888 | 2/20 | 0.44 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.40 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.39 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.39 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22454896 | 0.92 | CYP11B2 (0.55) | CYP11B2CYP11B1CYP17A1FLT3NPY5R | |
| SCHEMBL23343977 | 0.89 | CYP11B2 (0.48) | CYP11B2CYP11B1CYP17A1FLT3CYP19A1 | |
| SCHEMBL22016998 | 0.87 | PTGER4 (0.39) | AR | |
| SCHEMBL22017018 | 0.87 | PTGER4 (0.39) | AR | |
| SCHEMBL22016999 | 0.87 | PTGER4 (0.39) | AR | |
| SCHEMBL22454887 | 0.87 | PTGER4 (0.39) | AR | |
| SCHEMBL22454880 | 0.87 | PTGER4 (0.39) | AR | |
| SCHEMBL23344064 | 0.87 | CYP11B2 (0.46) | CYP11B2CYP11B1CYP17A1FLT3NPY5R | |
| SCHEMBL23344041 | 0.86 | CYP11B2 (0.52) | CYP11B2CYP11B1CYP17A1FLT3CYP19A1 | |
| SCHEMBL23296336 | 0.85 | CYP11B2 (0.46) | CYP11B2CYP11B1CYP17A1NPY5RMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200161562-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200161562-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | EML4, CELF2, L1CAM | CYP11B2 2625/4885CYP11B1 3110/4885CYP17A1 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.